One Brave Idea Research Award will support the search for new biomarkers and treatments. MIT is one of the institutions that will share the One Brave Idea Research Award to pursue new biomarkers for atherosclerosis — the hardening of the arteries that kills about 500,000 people in the United States…

Measuring enzyme levels could help doctors select appropriate treatments. MIT researchers have designed nanosensors that can profile tumors and may yield insight into how they will respond to certain therapies. The system is based on levels of enzymes called proteases, which cancer cells use to remodel their surroundings. Once adapted…

Dr. David Cohen, co-Director of the Harvard-MIT Health Sciences and Technology (HST) program and the Robert H. Ebert Professor of Medicine at Harvard Medical School, is stepping down after a nine-year tenure and will become Chief of Gastroenterology and Hepatology in the Department of Medicine at Weill Cornell Medical College…

Scientists at MIT, Massachusetts General Hospital, Living Proof, and Olivo Labs have developed a new material that can temporarily protect and tighten skin, and smooth wrinkles. With further development, it could also be used to deliver drugs to help treat skin conditions such as eczema and other types of dermatitis….

Pancreatic cancer is the third leading cause of cancer deaths in the United States, in part because it is very difficult for chemotherapy drugs to reach the pancreas, which is located deep within the abdomen. To help overcome that obstacle, researchers from MIT and Massachusetts General Hospital have now developed…